HomeWebinarsIn Vitro Pyrogen Detection in Pharma

In Vitro Pyrogen Detection in Pharma



For pharmaceutical companies, patient safety has always been the priority. That’s why pyrogen detection has become a mandatory Quality Control test for release of any parenteral drug. With the Monocyte Activation Test, the only in vitro test for the detection of the full range of pyrogens (including endotoxin and non-endotoxin pyrogens), it’s now time to move away from animal-based test for pyrogen detection. The new PyroMAT® system provides pharma companies with a robust solution to make the move to in vitro Pyrogen Test with a ready-to use kit!


Laure Robert

Merck KGaA, Darmstadt, Germany

Global Product Manager

Anja Fritsch

Confarma, France

Chief Scientific Officer

Webinar Introduction and Speakers Biography

What is a Pyrogen? Why to Conduct a Pyrogen Test? How to Detect Pyrogens? Current Status of Pyrogen Detection Methods?

Benefits of the PyroMAT® System and How to Use It

Validation of the PyroMAT® System

Real Life Case Study Using the PyroMAT® System

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon


Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.